PremiumCompany AnnouncementsTakeda Completes Share Repurchase to Optimize Capital Structure Takeda upgraded to Overweight from Equal Weight at Morgan Stanley Takeda Updates on Share Repurchase Progress PremiumCompany AnnouncementsTakeda and Protagonist Report Positive Phase 3 Results for Rusfertide in Polycythemia Vera Takeda Updates on Share Repurchase Progress Takeda announces EMA approval for Takhzyro two mL pre-filled pen option PremiumCompany AnnouncementsTakeda Revises FY2024 Financial Forecast with Significant Profit Increases Takeda Reports Robust Nine-Month Financial Performance and Positive Outlook Takeda Pharmaceutical Co (TKPHF) Q3 Earnings Cheat Sheet